✦ LIBER ✦
A phase 2 trial of combination therapy with thalidomide, arsenic trioxide, dexamethasone, and ascorbic acid (TADA) in patients with overlap myelodysplastic/myeloproliferative neoplasms (MDS/MPN) or primary myelofibrosis (PMF)
✍ Scribed by Nelli Bejanyan; Ramon V. Tiu; Azra Raza; Ania Jankowska; Matt Kalaycio; Anjali Advani; Josephine Chan; Yogen Saunthararajah; Lindsey Mooney; Jaroslaw P. Maciejewski; Mikkael A. Sekeres
- Book ID
- 112067048
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 236 KB
- Volume
- 118
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.